MIACH Orthopaedics completed US $22.5MM in financing to support manufacturing and continue clinical trials for the Bridge-Enhanced® ACL Repair (BEAR®) implant, designed to stimulate healing of torn anterior cruciate ligaments.
Bone Therapeutics reported all patients met the primary endpoint in the U.S. Phase I/IIA study of ALLOB® allogeneic bone-cell therapy in the treatment of delayed-union fractures.Â
Stryker entered into a definitive agreement to acquire instrument manufacturer Invuity for US $190MM in equity. The transaction is slated to close in 4Q18.